New technique could one day be used to target glioblastoma

Individuals who identified with a sexual or gender minority were more than twice as likely to report having epilepsy compared with the general population, survey

Re­gen­eron may soon be star­ing down an­oth­er com­peti­tor to its block­buster Eylea. San­doz’s biosim­i­lar can­di­date afliber­cept proved equiv­a­lent to the brand-name eye drug in a